Genetic influences of angiotensin-converting enzyme inhibitor response: an opportunity for personalizing therapy?

about

Cardiovascular pharmacogenomics: expectations and practical benefits.

P2860

Q38169969-34DD3ACD-1AEF-426D-BD86-F27AB1A300C6

P2860

Genetic influences of angiotensin-converting enzyme inhibitor response: an opportunity for personalizing therapy?

Item

http://www.wikidata.org/entity/Q38048836

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Genetic influences of angioten ...... ity for personalizing therapy?

@en

type

Item

label

Genetic influences of angioten ...... ity for personalizing therapy?

@en

prefLabel

Genetic influences of angioten ...... ity for personalizing therapy?

@en

P1476

Genetic influences of angioten ...... ity for personalizing therapy?

@en

P2093

Jasper J Brugts

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials.

Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology.

Renin-angiotensin system gene polymorphisms: potential mechanisms for their association with cardiovascular diseases.

Novel mode of action of angiotensin I converting enzyme inhibitors: direct activation of bradykinin B1 receptor.

ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Pat

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

Angiotensin-converting enzyme inhibition in cardiovascular disease: evidence with perindopril.

P304

1001-1009

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERC.12.83

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Maarten L Simoons

P577

2012-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23030290

http://www.w3.org/2001/XMLSchema#string

Genetic influences of angiotensin-converting enzyme inhibitor response: an opportunity for personalizing therapy?

about

P2860

P2860

Genetic influences of angiotensin-converting enzyme inhibitor response: an opportunity for personalizing therapy?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698